Faeth Therapeutics, Inc.
FTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829802
In the last 90 days, Faeth Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $333.8M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Faeth Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- −1 vs. Q1 2024
- Shares held
- 2.11M
- −201.6K (−8.7%) vs. Q1 2024
- Total value
- $1.31M
- −$1.12M (−46.1%) vs. Q1 2024
- New holders
- 5
- 6 more added
- Sold out
- 6
- 5 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $333.8M |
| Q1 2026 | 30 | $72.2M |
| Q4 2025 | 10 | $514.8K |
| Q3 2025 | 9 | $466.5K |
| Q2 2025 | 10 | $600.0K |
| Q1 2025 | 20 | $760.2K |
| Q4 2024 | 24 | $1.16M |
| Q3 2024 | 19 | $1.32M |
| Q2 2024 | 24 | $1.31M |
| Q1 2024 | 25 | $2.45M |
| Q4 2023 | 24 | $2.05M |
| Q3 2023 | 23 | $2.38M |
| Q2 2023 | 26 | $3.58M |
| Q1 2023 | 27 | $4.71M |
| Q4 2022 | 28 | $3.93M |
| Q3 2022 | 31 | $4.47M |
| Q2 2022 | 40 | $7.06M |
| Q1 2022 | 43 | $8.21M |
| Q4 2021 | 38 | $19.7M |
| Q3 2021 | 42 | $37.1M |
| Q2 2021 | 34 | $22.7M |
| Q1 2021 | 40 | $45.8M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Faeth Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | 650,000 | $403.1K | 0.13% | +650,000 | New |
| Vanguard Group Inc | 618,757 | $383.7K | 0.00% | +44,913+7.8% | Added |
| Renaissance Technologies LLC | 223,785 | $138.8K | 0.00% | +12,785+6.1% | Added |
| Boothbay Fund Management, LLC | 172,835 | $107.2K | 0.00% | +172,835 | New |
| Geode Capital Management, LLC | 163,139 | $101.2K | 0.00% | +26,821+19.7% | Added |
| Bridgeway Capital Management, LLC | 77,900 | $48.3K | 0.00% | −35,000−31.0% | Reduced |
| Northern Trust Corp | 25,983 | $16.1K | 0.00% | −66−0.3% | Reduced |
| State Street Corp | 25,774 | $16.0K | 0.00% | 00.0% | Unchanged |
| Cresset Asset Management, LLC | 19,671 | $12.2K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 18,600 | $11.5K | 0.00% | +18,600 | New |
| Citadel Advisors LLC | 15,366 | $9.53K | 0.00% | −8,498−35.6% | Reduced |
| Leo Wealth, LLC | 14,845 | $9.21K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 14,047 | $8.71K | 0.00% | +14,047 | New |
| Raymond James & Associates | 14,000 | $8.68K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 12,219 | $7.58K | 0.00% | 00.0% | Unchanged |
| Deuterium Capital Management, LLC | 11,000 | $6.82K | 0.01% | 00.0% | Unchanged |
| National Bank of Canada | 10,000 | $5.90K | 0.00% | +10,000 | New |
| BlackRock Inc. | 7,777 | $4.82K | 0.00% | −25,805−76.8% | Reduced |
| Tower Research Capital LLC (TRC) | 7,087 | $4.39K | 0.00% | +374+5.6% | Added |
| Banque Cantonale Vaudoise | 3,900 | $2.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 748 | $464 | 0.00% | +80+12.0% | Added |
| Bank of America Corp | 139 | $86 | 0.00% | −90,624−99.8% | Reduced |
| Qube Research & Technologies Ltd | 4 | $2 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 247 | $0 | 0.00% | +194+366.0% | Added |
| Newtyn Management, LLC | 0 | $0 | 0.00% | −930,230−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −32,587−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −19,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −10,176−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −139−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −133−100.0% | Sold out |